Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO1998050412) ESTROGENIC 19-NORADNROST-17-ONE DERIVATIVES WITH AN AROMATIC B-RING
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1998/050412 International Application No.: PCT/US1998/008455
Publication Date: 12.11.1998 International Filing Date: 28.04.1998
Chapter 2 Demand Filed: 10.11.1998
IPC:
C07J 1/00 (2006.01) ,C07J 17/00 (2006.01) ,C07J 31/00 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
J
STEROIDS
1
Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
J
STEROIDS
17
Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta[a]hydrophenanthrene skeleton
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
J
STEROIDS
31
Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
Applicants:
AMERICAN HOME PRODUCTS CORPORATION [US/US]; Five Giralda Farms Madison, NJ 07940-0874, US
Inventors:
SHAH, Syed, Muzafar; US
RAVEENDRANATH, Panolil; US
KAGAN, Michael, Z.; US
Agent:
ALICE, Ronald, W.; American Home Products Corporation Patent Law Dept. - 2B One Campus Drive Parsippany, NJ 07054 , US
WILEMAN, David, Francis; Wyeth Laboratories Huntercombe Lane South Taplow Maidenhead Berks SL6 0PH, GB
Priority Data:
08/850,42702.05.1997US
Title (EN) ESTROGENIC 19-NORADNROST-17-ONE DERIVATIVES WITH AN AROMATIC B-RING
(FR) DERIVES OESTROGENIQUES 19-NORADNROST-17-ONE RENFERMANT UN CYCLE B AROMATIQUE
Abstract:
(EN) This invention provides 3$g(b)-hydroxy-5,7,9-estratriene-17-one and a pharmaceutically acceptable salt of its 3-sulfate ester, which is useful as an estrogen.
(FR) La présente invention concerne une 3$g(b)-hydroxy-5,7,9-estratriène-17-one et un sel pharmaceutiquement acceptable de son 3-sulfate ester, qui est utilisée comme oestrogène.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, GW, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, UZ, VN, YU, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
MXPA/a/1999/010069KR1020010012155SG68216BRPI9809436AR012639EP0980382
JP2001525806 CN1254344CA2288999AU1998071646